Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury
Anna Rinaldi, Hélène Lazareth, Virginie Poindessous, Ivan Nemazanyy, Julio L. Sampaio, Daniele Malpetti, Yohan Bignon, Maarten Naesens, Marion Rabant, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet
Anna Rinaldi, Hélène Lazareth, Virginie Poindessous, Ivan Nemazanyy, Julio L. Sampaio, Daniele Malpetti, Yohan Bignon, Maarten Naesens, Marion Rabant, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet
View: Text | PDF
Research Article Nephrology Transplantation

Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury

  • Text
  • PDF
Abstract

Energy metabolism failure in proximal tubule cells (PTCs) is a hallmark of chronic kidney injury. We combined transcriptomic, metabolomic, and lipidomic approaches in experimental models and patient cohorts to investigate the molecular basis of the progression to chronic kidney allograft injury initiated by ischemia/reperfusion injury (IRI). The urinary metabolome of kidney transplant recipients with chronic allograft injury and who experienced severe IRI was substantially enriched with long chain fatty acids (FAs). We identified a renal FA-related gene signature with low levels of carnitine palmitoyltransferase 2 (Cpt2) and acyl-CoA synthetase medium chain family member 5 (Acsm5) and high levels of acyl-CoA synthetase long chain family member 4 and 5 (Acsl4 and Acsl5) associated with IRI, transition to chronic injury, and established chronic kidney disease in mouse models and kidney transplant recipients. The findings were consistent with the presence of Cpt2–Acsl4+Acsl5+Acsm5– PTCs failing to recover from IRI as identified by single-nucleus RNA-Seq. In vitro experiments indicated that ER stress contributed to CPT2 repression, which, in turn, promoted lipids’ accumulation, drove profibrogenic epithelial phenotypic changes, and activated the unfolded protein response. ER stress through CPT2 inhibition and lipid accumulation engaged an auto-amplification loop leading to lipotoxicity and self-sustained cellular stress. Thus, IRI imprints a persistent FA metabolism disturbance in the proximal tubule, sustaining the progression to chronic kidney allograft injury.

Authors

Anna Rinaldi, Hélène Lazareth, Virginie Poindessous, Ivan Nemazanyy, Julio L. Sampaio, Daniele Malpetti, Yohan Bignon, Maarten Naesens, Marion Rabant, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet

×

Figure 4

The Cpt2–Acsl4+Acsl5+Acsm5– signature is a feature of established CKD.

Options: View larger image (or click on image) Download as PowerPoint
The Cpt2–Acsl4+Acsl5+Acsm5– signature is a feature of established CKD.
(...
(A) Representative photomicrograph of neutral lipid accumulation in PTCs evaluated by Oil Red O staining in kidney allografts from 3 KTRs with chronic injury of various severity. Original magnification, ×40. Creat, creatinine; PU, urine protein-to-creatinine ratio. (B) Expression of Cpt2, Acsl4, Acsl5, and Acsm5 transcripts by expression profiling by array in the tubulointerstitial compartment of 24 healthy kidneys donors and 10 kidneys with diabetic kidney disease. Data are from public repositories (NCBI GEO accession GSE30122). Bars represent mean ± SD. P values were computed with a Student’s t test. (C) Expression of Cpt2, Acsl4, Acsl5, and Acsm5 transcripts by RNA-Seq in whole kidneys of 12- and 24-week-old UmodC147W/+ mice and wild-type mice (5 to 10 mice per condition). Data are from public repositories (GEO accession GSE102566). Bars represent mean ± SD. P values were computed with a Student’s t test. FPKM, fold-change per kilobase million. (D) Intrarenal expression of CPT2, ACSL4, ACSL5, and ACSM5 transcript levels as a function of the renal function (eGFR) of 201 healthy kidney donors and individuals with CKD. Data are from public repositories (Nephroseq). R is the Pearson’s correlation coefficient, and the P values were computed with a Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts